For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
New patient jets in from US – soon this GP is pleading with his insurance company
+Print Archive
Practice
New patient jets in from US – soon this GP is pleading with his insurance company
Wednesday 21 November 2018, 12:00 AM

Alex’s close friend convinced her to come back home to explore her medical problem
REAL CASES
An expat returns with a hip problem rather than bankrupt herself by using the US health system; however, her mysterious nature causes this GP a moment of sheer panic
Did the six weeks I had taken to become concerned about her metastases constitute a failure to diagnose?
Insurance companies – can’t live with th
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.